Beijing Tongrentang Co Ltd
SSE:600085
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
31.21
54.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Beijing Tongrentang Co Ltd
Accrued Liabilities
Beijing Tongrentang Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Beijing Tongrentang Co Ltd
SSE:600085
|
Accrued Liabilities
ÂĄ747.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
||
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accrued Liabilities
ÂĄ2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accrued Liabilities
ÂĄ620.1m
|
CAGR 3-Years
74%
|
CAGR 5-Years
53%
|
CAGR 10-Years
31%
|
||
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accrued Liabilities
ÂĄ128.5m
|
CAGR 3-Years
456%
|
CAGR 5-Years
130%
|
CAGR 10-Years
63%
|
||
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accrued Liabilities
ÂĄ1.5B
|
CAGR 3-Years
74%
|
CAGR 5-Years
54%
|
CAGR 10-Years
46%
|
||
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accrued Liabilities
ÂĄ146m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Beijing Tongrentang Co Ltd
Glance View
Nestled in the heart of Beijing's bustling historic district, Beijing Tongrentang Co. Ltd. trace their origins back to 1669 during the Qing Dynasty. This venerable institution has often been heralded as the steward of traditional Chinese medicine (TCM), expertly bridging over three centuries of heritage with the demands of modern healthcare. The company's deep-rooted ethos is centered on the enduring principles of TCM, which emphasize balance and holistic well-being, a philosophy that they have meticulously preserved and adapted over generations. The intricate potions, herbal remedies, and elaborate tonics they craft are derived from a unique blend of ancient recipes and rigorous quality standards, ensuring both authenticity and efficacy. This reverence for tradition, coupled with a commitment to innovation, underpin the strength and credibility of Tongrentang's brand, allowing it to not only maintain but also expand its standing globally. From the cobblestones of Beijing, Tongrentang's operations today encompass a sophisticated network of production facilities, retail outlets, and strategic partnerships, turning the company into a formidable player in the health sector. While steeped in history, this hallmark of traditional Chinese medicine makes its earnings through a modern business model that includes pharmaceuticals, healthcare services, and retail. Their production capabilities boast advanced manufacturing technologies that complement their traditional processes, ensuring scalable and efficient operations without compromising the character of their products. Retail remains a core avenue, with a vast array of stores in China and abroad that serve as conduits for both commerce and education, introducing new generations to TCM. Additionally, Tongrentang has successfully ventured into healthcare services, with clinics providing wellness treatments and consultations that encapsulate the essence of their medicinal philosophy, thus diversifying income streams while deepening consumer engagement with its storied brand.
See Also
What is Beijing Tongrentang Co Ltd's Accrued Liabilities?
Accrued Liabilities
747.3m
CNY
Based on the financial report for Sep 30, 2024, Beijing Tongrentang Co Ltd's Accrued Liabilities amounts to 747.3m CNY.
What is Beijing Tongrentang Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
15%
Over the last year, the Accrued Liabilities growth was 21%. The average annual Accrued Liabilities growth rates for Beijing Tongrentang Co Ltd have been 15% over the past three years , 12% over the past five years , and 15% over the past ten years .